Submitted by Anonymous (not verified) on 11 February 2025 - 15:09
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised
Source: